Our new paper from @ErasmusMCPH in Lancet Infectious Diseases demonstrating indoor residual spraying has been helpful in visceral leishmaniasis infection control.
Visceral Leishmaniasis @NtdModelling members L.Coffeng @AnanthuJames & S.Vlas contributed to new study by Dr M Coleman, it shows large-scale IRS with alphacypermethrin cut sandflies by 27% & village-wide IRS could reduce VL cases by up to 40% https://t.co/rD1TJoDAYt
🔍 Lymphatic Filariasis - recent study by @ananthuJames et al has shown that triple-drug therapy (IDA) is a game-changer in the fight against LF.
🛑 But when do we stop Mass Drug Administration (MDA) with IDA? It's crucial to assess transmission suppression accurately. 🧵⬇️
Dear #IDtwitter colleagues - at @PInfections we have too few recommenders and reviewers with experience in field #epidemiology and social studies. If you know someone who might be interested in joining, please get in touch. All it takes is a CV and some basic vetting. TIA!
Thomas Hambridge and colleagues have published a paper in BMC titled”Establishing a standard method
for analysing case detection delay in leprosy using a Bayesian modelling approach”
Click here to learn more👉 https://t.co/z4TINsiPT9
My work from my postdoc lab at @iiscbangalore showing the early CD4 count difference b/w #HIV infected #MSM (#gay men) & #heterosexuals to be a result of the transmission routes being different is published in @PLOSPathogens: https://t.co/VGl3J9Cd9V.
(https://t.co/p6vCcRqNqM)